22.06.2023
Acino appoints Andrew Bird as Interim CEO
We are pleased to announce that Andrew Bird, currently Head of META at Acino, will assume the role of interim...
Acino
News
31.05.2023
Acino joins forces with MultiCare to enhance patient services across Egypt and Middle East
Partnership covers the marketing and distribution of select products including new therapeutic areas of diabetes and hypercholesterolemia, in addition to...
15.05.2023
Acino announces collaboration with Janssen to strengthen patient access in South Africa
Acino South Africa to market and sell several Janssen products mainly within the pain, neuroscience and anti-fungal therapeutic areas to...
10.05.2023
Acino attains Level 1 B-BBEE status in South Africa for the fourth consecutive year
Our approach to diversity resonates with South Africa’s philosophy of equal opportunity, and we have achieved Level 1 B-BBEE status...
09.05.2023
Meet Armel Ananfah, Head of Analytical Science & Technology (AS&T)
Do you want to know what it’s like to work at Acino? Hear it from Armel Ananfah, Head of Analytical...
02.05.2023
Acino is EcoVadis certified
The world’s most trusted provider of business sustainability ratings, EcoVadis has awarded Acino its first Bronze medal based on the...
20.04.2023
Meet Katrin Madissoo, Site Head Acino Estonia
Dedication and expertise are key qualities needed to deliver flexible solutions to our customers, and we are fortunate to have...
20.03.2023
Acino announces integration of Pharmax Pharmaceuticals, strengthening presence and capabilities in the Middle East
Over 100 Pharmax employees and its UAE-based manufacturing site to enhance Acino’s expertise and expanding portfolio in the region Zurich,...
15.03.2023
Planting Ghaf trees in Dubai
Acino recently partnered with Companies for Good to take a step towards environmental conservation. As part of this initiative, our...